# ENDRA Life Sciences Inc.: Form DEF 14A, filed May 10, 2018

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: DEF 14A
- Filed: 2018-05-10
- Accepted by EDGAR: May 10, 2018, 16:08 ET
- Period: 2018-06-12
- Accession: 0001213900-18-005842
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000121390018005842/def14a061218_endralife.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000121390018005842/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000121390018005842/def14a061218_endralife.htm

Filed May 10, 2018.
Source: SEC EDGAR, the filing index for accession 0001213900-18-005842. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.
